Navigation Links
SenesTech Scientists Attend International Workshop on Fertility in New Zealand

FLAGSTAFF, Ariz., March 4 /PRNewswire/ -- SenesTech, Inc. scientists, Drs. Loretta Mayer, Cheryl Dyer and Timothy Vail, were invited to attend the Third International Workshop on Fertility Control in Wildlife Management in Lincoln, New Zealand where they presented SenesTech's latest developments in humane animal population management. This invitation only meeting is organized by the governments of Australia, the United States, New Zealand and Great Britain, who are working together to support the development of new, more effective methods for wildlife management, and by treaty, will accept the research done in any one of the four countries. In previous years attendees have presented research on contraceptive vaccines, parasite-vectored fertility control, and oral bait delivery systems for fertility control. This invitation reflects the cutting edge nature of SenesTech's research into chemical fertility management in the rice field rat of Southeast Asia as it is the only non-governmental entity invited to the workshop during the four year history of this annual meeting.

SenesTech's initial product, ContraPest(TM), which is being developed to counteract the rice rat plague in the rice producing countries of the world, will dramatically improve rice yields in Southeast Asia by reducing the rice field rat population. Over half of the worlds 6 billion people depend on rice as their primary food source and Southeast Asia produces over 84% of this resource. Currently, 1/5-1/3 of the Southeast Asian rice crop is severely damaged by these rice field rats. SenesTech's product is a unique non-toxic, environmentally sound oral bait that can dramatically reduce this pest population, resulting in a substantial reduction in the devastation caused by rice field rats in just one growing season. A simple 10% increase in rice production as a result of population management through ContraPest(TM) will feed an additional 380 million people.

An additional SenesTech product, ChemSpay(TM) is the only product currently under development that has been shown to induce permanent sterility in female dogs. Further, SenesTech has a prototype drug delivery system that allows for a single exposure to induce sterility in dogs.

SenesTech is partnered with Dr. Lyn Hinds, the Senior Principal Research Scientist of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Australia and Dr. Sudamaji at the Indonesian Centre for Rice Research (ICRR).

About: (SenesTech, Inc.) SenesTech is a platform technology company located in Flagstaff, Arizona, on the Northern Arizona Center for Emerging Technology campus. SenesTech specializes in humane animal population management products for companion animals and wildlife.

SOURCE SenesTech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SenesTech, Inc. Appoints Susan Airhart to Board of Directors
2. SenesTech, Inc. Commences Product Registration Process With Australian Government
3. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
4. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
5. Scientists prove graphenes edge structure affects electronic properties
6. Obama Advisor Joins Connecticut and International Scientists at New Haven Stem Cell Symposium
7. Scientists publish complete genetic blueprint of key biofuels crop
8. 2010 Japan Prize to Honor Scientists and Researchers in Industrial Production/Production Technology and Biological Production/Environment Fields
9. BOXX Personal Supercomputer for Research Scientists Featured at SC08
10. NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
11. Scientists restore movement to paralyzed limbs through artificial brain-muscle connections
Post Your Comments:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):